Role of Peptidoglycan Subtypes in the Pathogenesis of Bacterial Cell Wall Arthritis

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2003 Sep 16

PMID 12972477

Citations 21

Authors

E Simelyte

M Rimpilainen

X Zhang

P TOIVANEN

Affiliations

Soon will be listed here.

Abstract

Background: Bacterial cell wall (CW) arthritis develops in susceptible strains of rats after a single intraperitoneal injection of the CW from certain bacterial species, both pathogenic and non-pathogenic. For the development of chronic bacterial CW arthritis, the structure of the bacterial peptidoglycan (PG) has been found to be decisive.

Objective: To define the role of PG subtypes in the pathogenesis of chronic bacterial CW arthritis.

Method: Arthritis was induced with CWs of Lactobacillus plantarum, L casei B, L casei C, and L fermentum. Gas chromatography-mass spectrometry was used to measure the presence of CW derived muramic acid in the liver and to determine PG subtypes. CWs were also tested for their resistance to lysozyme in vitro.

Results: These results and those published previously indicate that PGs of CWs which induce chronic arthritis, no matter whether they were derived from strains of Streptococcus, Bifidobacterium, Collinsella, or Lactobacillus, all have lysine as the third amino acid of the PG stem peptide, representing PG subtypes A3alpha and A4alpha. Those strains which induce only transient acute arthritis or no arthritis at all do not have lysine in this position, resulting in different PG subtypes.

Conclusions: In vivo degradation of only those PGs with the subtypes A3alpha and A4alpha leads to the occurrence of large CW fragments, which persist in tissue and have good proinflammatory ability. CWs with other PG subtypes, even if they are lysozyme resistant, do not cause chronic arthritis, because the released fragments are not phlogistic. It is emphasised that a variety of microbial components not causing inflammation have been found in animal and human synovial tissue.

Citing Articles

High fat diet increases the severity of collagen-induced arthritis in mice by altering the gut microbial community.

Zhang Y, Zhang J, Liu Y, Ren S, Tao N, Meng F Adv Rheumatol. 2024; 64(1):44.

PMID: 38816873 DOI: 10.1186/s42358-024-00382-y.

Gut-Joint Axis: Impact of Bifidobacterial Cell Wall Lipoproteins on Arthritis Development.

Piva F, Gervois P, Karrout Y, Sane F, Romond M Nutrients. 2023; 15(23).

PMID: 38068720 PMC: 10708502. DOI: 10.3390/nu15234861.

Clinically proven natural products, vitamins and mineral in boosting up immunity: A comprehensive review.

Al Mahmud A, Siddiqui S, Karim M, Al-Mamun M, Akhter S, Sohel M Heliyon. 2023; 9(4):e15292.

PMID: 37089292 PMC: 10079597. DOI: 10.1016/j.heliyon.2023.e15292.

The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis.

Zhu J, Wang T, Lin Y, Xiong M, Chen J, Jian C Front Microbiol. 2022; 13:931431.

PMID: 36329847 PMC: 9623673. DOI: 10.3389/fmicb.2022.931431.

Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases.

Wang L, Xu H, Yang H, Zhou J, Zhao L, Zhang F Front Immunol. 2022; 13:952398.

PMID: 36203617 PMC: 9530352. DOI: 10.3389/fimmu.2022.952398.

References

Wilder R, Allen J, Wahl L, Calandra G, Wahl S . The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Comparative studies in arthritis resistant and susceptible inbred rat strains. Arthritis Rheum. 1983; 26(12):1442-51. DOI: 10.1002/art.1780261205. View

GUINAND M, Ghuysen J, Schleifer K, Kandler O . The peptidoglycan in walls of Butyribacterium rettgeri. Biochemistry. 1969; 8(1):200-7. DOI: 10.1021/bi00829a029. View

Martin S, Karnovsky M, Krueger J, PAPPENHEIMER J, Biemann K . Peptidoglycans as promoters of slow-wave sleep. I. Structure of the sleep-promoting factor isolated from human urine. J Biol Chem. 1984; 259(20):12652-8. View

Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A . The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis. 1985; 151(5):859-68. DOI: 10.1093/infdis/151.5.859. View

Sartor R, CROMARTIE W, Powell D, Schwab J . Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology. 1985; 89(3):587-95. DOI: 10.1016/0016-5085(85)90455-x. View

Hungerer K, Fleck J, Tipper D . Structure of the cell wall peptidoglycan of Lactobacillus casei RO94. Biochemistry. 1969; 8(9):3567-77. DOI: 10.1021/bi00837a012. View

Schleifer K, Kandler O . Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev. 1972; 36(4):407-77. PMC: 408328. DOI: 10.1128/br.36.4.407-477.1972. View

Kohashi O, Pearson C, Watanabe Y, Kotani S, Koga T . Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds. J Immunol. 1976; 116(6):1635-9. View

CROMARTIE W, CRADDOCK J, Schwab J, ANDERLE S, Yang C . Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med. 1977; 146(6):1585-602. PMC: 2181919. DOI: 10.1084/jem.146.6.1585. View

10.

Stewart-Tull D . The immunological activities of bacterial peptidoglycans. Annu Rev Microbiol. 1980; 34:311-40. DOI: 10.1146/annurev.mi.34.100180.001523. View

11.

Chang Y, Pearson C, CHEDID L . Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan. J Exp Med. 1981; 153(4):1021-6. PMC: 2186125. DOI: 10.1084/jem.153.4.1021. View

12.

Fox A, Brown R, ANDERLE S, Chetty C, CROMARTIE W, GOODER H . Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls. Infect Immun. 1982; 35(3):1003-10. PMC: 351147. DOI: 10.1128/iai.35.3.1003-1010.1982. View

13.

Eisenberg R, Fox A, Greenblatt J, ANDERLE S, CROMARTIE W, Schwab J . Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats. Infect Immun. 1982; 38(1):127-35. PMC: 347707. DOI: 10.1128/iai.38.1.127-135.1982. View

14.

Lehman T, Allen J, Plotz P, Wilder R . Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum. 1983; 26(10):1259-65. DOI: 10.1002/art.1780261013. View

15.

ANDERLE S, Allen J, Wilder R, Eisenberg R, CROMARTIE W, Schwab J . Measurement of streptococcal cell wall in tissues of rats resistant or susceptible to cell wall-induced chronic erosive arthritis. Infect Immun. 1985; 49(3):836-7. PMC: 261291. DOI: 10.1128/iai.49.3.836-837.1985. View

16.

Lehman T, Allen J, Plotz P, Wilder R . Bacterial cell wall composition, lysozyme resistance, and the induction of chronic arthritis in rats. Rheumatol Int. 1985; 5(4):163-7. DOI: 10.1007/BF00541517. View

17.

Stimpson S, Brown R, ANDERLE S, Klapper D, CLARK R, CROMARTIE W . Arthropathic properties of cell wall polymers from normal flora bacteria. Infect Immun. 1986; 51(1):240-9. PMC: 261093. DOI: 10.1128/iai.51.1.240-249.1986. View

18.

Wahl S, Hunt D, Allen J, Wilder R, Paglia L, Hand A . Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis. J Exp Med. 1986; 163(4):884-902. PMC: 2188069. DOI: 10.1084/jem.163.4.884. View

19.

Stimpson S, Esser R, CROMARTIE W, Schwab J . Comparison of in vivo degradation of 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci. Infect Immun. 1986; 52(2):390-6. PMC: 261011. DOI: 10.1128/iai.52.2.390-396.1986. View

20.

Kotani S, Tsujimoto M, Koga T, Nagao S, Tanaka A, Kawata S . Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed Proc. 1986; 45(11):2534-40. View